KalVista Pharmaceuticals (KALV) Payables (2016 - 2024)
Historic Payables for KalVista Pharmaceuticals (KALV) over the last 10 years, with Q4 2024 value amounting to $5.7 million.
- KalVista Pharmaceuticals' Payables changed N/A to $5.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.7 million, marking a year-over-year change of. This contributed to the annual value of $9.1 million for FY2024, which is N/A changed from last year.
- As of Q4 2024, KalVista Pharmaceuticals' Payables stood at $5.7 million.
- Over the past 5 years, KalVista Pharmaceuticals' Payables peaked at $10.8 million during Q3 2024, and registered a low of $641000.0 during Q1 2021.
- Over the past 4 years, KalVista Pharmaceuticals' median Payables value was $4.0 million (recorded in 2023), while the average stood at $4.4 million.
- In the last 5 years, KalVista Pharmaceuticals' Payables tumbled by 7827.85% in 2021 and then skyrocketed by 11328.06% in 2024.
- KalVista Pharmaceuticals' Payables (Quarter) stood at $2.2 million in 2020, then crashed by 70.5% to $641000.0 in 2021, then skyrocketed by 663.81% to $4.9 million in 2023, then rose by 16.95% to $5.7 million in 2024.
- Its Payables was $5.7 million in Q4 2024, compared to $5.2 million in Q4 2024 and $10.8 million in Q3 2024.